Applied Biosciences Corp.
APPB · OTC
3/31/2021 | 3/31/2020 | 3/31/2019 | 3/31/2018 | |
|---|---|---|---|---|
| Revenue | $89 | $723 | $707 | $198 |
| % Growth | -87.7% | 2.3% | 257.9% | – |
| Cost of Goods Sold | $407 | $437 | $522 | $156 |
| Gross Profit | -$318 | $287 | $185 | $42 |
| % Margin | -358.5% | 39.6% | 26.2% | 21.3% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $0 | $2,093 | $953 |
| SG&A Expenses | $375 | $3,376 | $2,791 | $1,310 |
| Sales & Mktg Exp. | $0 | $0 | $698 | $357 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $375 | $3,376 | $2,832 | $1,535 |
| Operating Income | -$693 | -$3,090 | -$2,646 | -$600 |
| % Margin | -781.3% | -427.1% | -374.3% | -303.5% |
| Other Income/Exp. Net | -$207 | -$1,876 | -$33 | -$156 |
| Pre-Tax Income | -$900 | -$4,966 | -$2,679 | -$2,387 |
| Tax Expense | $0 | $0 | $0 | $883 |
| Net Income | -$767 | -$4,674 | -$2,629 | -$2,376 |
| % Margin | -865.3% | -646.1% | -371.9% | -1,202.8% |
| EPS | -0.04 | -0.34 | -0.22 | -0.16 |
| % Growth | 88.4% | -54.5% | -37.5% | – |
| EPS Diluted | -0.056 | -0.34 | -0.22 | -0.16 |
| Weighted Avg Shares Out | 13,706 | 13,706 | 11,915 | 15,071 |
| Weighted Avg Shares Out Dil | 13,706 | 13,706 | 11,915 | 15,071 |
| Supplemental Information | – | – | – | – |
| Interest Income | $1 | $0 | $0 | $0 |
| Interest Expense | $0 | $1,009 | $649 | $0 |
| Depreciation & Amortization | $174 | $204 | $41 | $225 |
| EBITDA | -$725 | -$3,753 | -$1,990 | -$2,162 |
| % Margin | -817.9% | -518.8% | -281.4% | -1,094.4% |